Synopsys, Inc. (NASDAQ:SNPS – Get Free Report) insider Geus Aart De sold 27,753 shares of the business’s stock in a transaction on Friday, July 5th. The shares were sold at an average price of $618.58, for a total transaction of $17,167,450.74. Following the transaction, the insider now owns 106,983 shares in the company, valued at approximately $66,177,544.14. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
Geus Aart De also recently made the following trade(s):
- On Monday, July 8th, Geus Aart De sold 5,448 shares of Synopsys stock. The shares were sold at an average price of $620.95, for a total value of $3,382,935.60.
- On Wednesday, July 3rd, Geus Aart De sold 2,789 shares of Synopsys stock. The stock was sold at an average price of $610.94, for a total transaction of $1,703,911.66.
- On Monday, July 1st, Geus Aart De sold 5,893 shares of Synopsys stock. The stock was sold at an average price of $602.00, for a total transaction of $3,547,586.00.
- On Thursday, June 27th, Geus Aart De sold 8,158 shares of Synopsys stock. The shares were sold at an average price of $602.59, for a total transaction of $4,915,929.22.
- On Tuesday, June 25th, Geus Aart De sold 4,212 shares of Synopsys stock. The stock was sold at an average price of $600.05, for a total value of $2,527,410.60.
Synopsys Stock Performance
NASDAQ SNPS opened at $619.56 on Thursday. Synopsys, Inc. has a fifty-two week low of $418.51 and a fifty-two week high of $629.38. The firm has a market capitalization of $94.93 billion, a P/E ratio of 67.34, a PEG ratio of 3.97 and a beta of 1.07. The stock has a 50-day simple moving average of $582.85 and a two-hundred day simple moving average of $559.61.
Institutional Trading of Synopsys
Several hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in shares of Synopsys by 2.1% during the 1st quarter. Vanguard Group Inc. now owns 13,829,357 shares of the semiconductor company’s stock worth $7,903,478,000 after acquiring an additional 278,265 shares in the last quarter. Capital World Investors boosted its position in Synopsys by 12.5% during the first quarter. Capital World Investors now owns 7,369,890 shares of the semiconductor company’s stock worth $4,211,892,000 after purchasing an additional 818,485 shares in the last quarter. Price T Rowe Associates Inc. MD grew its holdings in Synopsys by 39.6% in the first quarter. Price T Rowe Associates Inc. MD now owns 5,337,602 shares of the semiconductor company’s stock valued at $3,050,441,000 after purchasing an additional 1,514,449 shares during the period. Massachusetts Financial Services Co. MA increased its position in shares of Synopsys by 6.3% in the fourth quarter. Massachusetts Financial Services Co. MA now owns 2,565,534 shares of the semiconductor company’s stock valued at $1,321,019,000 after buying an additional 153,053 shares in the last quarter. Finally, Norges Bank acquired a new position in shares of Synopsys during the 4th quarter worth approximately $1,272,143,000. Institutional investors and hedge funds own 85.47% of the company’s stock.
Analyst Upgrades and Downgrades
Several brokerages recently weighed in on SNPS. StockNews.com upgraded Synopsys from a “hold” rating to a “buy” rating in a research note on Monday, March 18th. Robert W. Baird upped their price objective on shares of Synopsys from $645.00 to $661.00 and gave the company an “outperform” rating in a report on Tuesday, July 2nd. Needham & Company LLC reiterated a “buy” rating and issued a $660.00 target price on shares of Synopsys in a research note on Thursday, May 23rd. KeyCorp upped their price target on shares of Synopsys from $675.00 to $690.00 and gave the company an “overweight” rating in a research note on Thursday, June 27th. Finally, Piper Sandler lifted their price objective on shares of Synopsys from $672.00 to $687.00 and gave the stock an “overweight” rating in a research note on Wednesday. Eleven analysts have rated the stock with a buy rating, According to MarketBeat, Synopsys presently has an average rating of “Buy” and an average price target of $627.18.
Check Out Our Latest Stock Report on SNPS
About Synopsys
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
See Also
- Five stocks we like better than Synopsys
- Are Penny Stocks a Good Fit for Your Portfolio?
- This Stock’s Price Shifts Into High Gear With Analyst Upgrades
- Best Stocks Under $5.00
- AI Boosts Glass Tech Leader Stock: Shares Up 75% and More to Come
- What is a Death Cross in Stocks?
- AI Partnership Boosts This Top Tech Stock: Ready for More Gains?
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.